Aaron Mansfield, M.D.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Travel
    Ineligible company: 
    Roche
    Date added: 
    07/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    AbbVie
    Topic: 
    Advisory Board
    Date added: 
    07/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    AstraZeneca
    Topic: 
    Advisory Board
    Date added: 
    07/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    BMS
    Topic: 
    Advisory Board
    Date added: 
    07/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Genentech
    Topic: 
    Advisory Board
    Date added: 
    07/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Janssen
    Topic: 
    Steering Committee
    Date added: 
    07/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Johnson & Johnson Global Services
    Topic: 
    Steering Committee
    Date added: 
    07/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Chugai Pharmaceutical Co Ltd (Roche)
    Topic: 
    Speaking Engagement
    Date added: 
    07/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Rising Tide
    Topic: 
    Grant Reviewer
    Date added: 
    07/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    TRIPTYCH Health Partners
    Topic: 
    Expert Think Tank
    Date added: 
    07/26/2022

Pages

Return to 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes